Business
Currency:USD
2024/Q3
Stock NameRevenueRatio
Minimal Residual Disease (MRD)37.47M80.69%
Immune Medicine8.97M19.31%
Region
Currency:USD
2023/FY
Stock NameRevenueRatio
United States170.28M100.00%